CuriRx is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the comprehensive development and manufacturing of pharmaceutical products. With a strong focus on innovation and quality, CuriRx offers a wide range of analytical methods, testing, formulation and bioprocessing services that encompass the entire drug development lifecycle.
From early-stage formulation development to GMP manufacturing. CuriRx delivers customized solutions tailored to the unique needs of each client. Their state-of-the-art facilities and advanced technologies enable them to manage complex projects for all types of modalities, including biologics, and specialty pharmaceuticals. By leveraging our extensive scientific expertise and cutting-edge technologies, CuriRx ensures the highest quality and efficient execution of every project, ultimately accelerating the time to market for their clients' products.
In addition to the core CDMO services, CuriRx excels in providing robust analytical and quality testing solutions. The CuriLytics platform, for instance, utilizes high-resolution mass spectrometry and orthogonal approach to deliver comprehensive Chemistry, Manufacturing, and Control (CMC) analytical services. This platform supports the detailed characterization of complex Biotherapeutics, including recombinant proteins, monoclonal antibodies, and gene therapy products.
Our commitment to excellence is further demonstrated through their rigorous adherence to regulatory standards and focus on continuous improvement. By fostering a collaborative approach and maintaining transparent communication, CuriRx builds strong partnerships with their clients, ensuring that each project achieves its full potential and meets the highest standards of quality and safety.